"Tumour marker guided" salvage treatment prolongs survival of breast cancer patients: Final report of a 7-year study

Biomedicine and Pharmacotherapy

Volumn 57, Issue 10, 2003, Pages 452-459

  Nicolini, Andrea ^a   Carpi, Angelo ^a   Michelassi, Claudio ^a   Spinelli, Claudio ^a   Conte, Massimo ^a   Miccoli, Paolo ^a   Fini, M ^b   Giardino, R ^b  

^a UNIVERSITY OF PISA   (Italy)

^b Bologna Italy   (Italy)

Author keywords

Breast cancer; Metastasis; Treatment; Tumour markers

Indexed keywords

ANTINEOPLASTIC AGENT; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIBODY; MEDROXYPROGESTERONE; TAMOXIFEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INSTRUMENTATION; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL EXAMINATION; METASTASIS; MULTIVARIATE ANALYSIS OF VARIANCE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGICAL PARAMETERS; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; SALVAGE THERAPY; STATISTICAL SIGNIFICANCE;

EID: 0345306243     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2003.09.004     Document Type: Article

References (28)

1. Broyn T., Froyen J. Evaluation of routine follow-up after surgery for breast carcinoma. Acta Chir Scand. 148:1982;401-404.
2. Dewar J.A., Kerr G.R. Value of routine follow-up of women treated for early carcinoma of the breast. Br Med J. 291:1985;1464-7146.
3. Muss H.B., McNamara M.J., Connelly R.A. Follow-up after stage II breast cancer: a comparative study of relapsed versus nonrelapsed patients. Am J Clin Oncol. 11:1988;451-455.
4. Ormiston M.C., Timoney A.G., Quareshi A.R. Is follow up of patients after surgery for breast cancer worthwhile? J R Soc Med. 78:1985;920-921.
5. Pandya K.J., McFadden E.T., Kalish L.A., Tormey D.C., Taylor I.V.S.G., Falkson J.A. Retrospective study of earliest indicators of recurrence in patients on Eastern Cooperative Oncology Group adjuvant chemotherapy trials for breast cancer. A preliminary report. Cancer. 55:1985;202-205.
6. Schapira D.V., Urban N.A. Minimalist policy for breast cancer surveillance. J Am Med Assoc. 265:1991;380-382.
7. Zwaveling A., Albers G.H., Felthius W., Hermans J. An evaluation of routine follow-up for detection of breast cancer recurrences. J Surg Oncol. 34:1987;194-197.
8. Rosselli del Turco M., Palli D., Cariddi A., Ciatto S., Pacini P., Distante V. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. J Am Med Assoc. 271:1994;1593-1597.
9. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. J Am Med Assoc. 271:1994;1587-1592.
10. Harms J.E., Welch D.R. MDA-MB-435 human breast carcinoma metastasis to bone. Clin Exp Metastasis. 20:(4):2003;327-334.
11. Manoglas S.C., Weinstein R.S., Jilka R.L. Basic principles of bone physiology. Body J.J. Tumor bone diseases and osteoporosis in cancer patients. 2000;1-20 Marcel Dekker, New York.
12. Nicolini A., Carpi A., Di Marco G., Giuliani L., Giordani R., Palla S. A rational postoperative follow-up with carcinoembryonic antigen, tissue polypeptide antigen, and urinary hydroxyproline in breast cancer patients. Cancer. 63:1989;2037-2046.
13. Nicolini A., Colombini C., Luciani L., Carpi A., Giuliani L. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. Br J Cancer. 64:1991;154-158.
14. Nicolini A., Anselmi L., Michelassi C., Carpi A. Prolonged survival by "early" salvage treatment of breast cancer patients: a retrospective 6-year study. Br J Cancer. 76:1997;1106-1111.
15. Nicolini A., Carpi A. The post-operative follow-up of breast cancer patients: overview and progress on the use of tumor markers. Tumor Biol. 21:2000;235-248.
16. Nicolini A., Ferrari P., Sagripanti A., Carpi A. The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy. Br J Cancer. 79:1999;1443-1447.
17. Black W.C., Welch H.G. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. New Engl J Med. 328:1993;1237-1243.
18. Bonadonna G., Valagussa P. Neoplasie della mammella. Bonadonna G., Robustelli della Cuna G. Medicina oncologica. 1999;529-563 Masson, Milan.
19. Rutgers E.J.T.H., Van Slooten E., Kluck H.M. Follow-up after treatment of primary breast cancer. Br J Surg. 76:1989;187-190.
20. Jaiyesimi I.A., Buzdar A.U., Decker D.A., Hortobagyi G.N. Use of tamoxifen for breast cancer: 28 years later. J Clin Oncol. 13:1995;513-529.
21. Norris B., Pritchard K.I., James K., et al. Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada clinical trials group study MA8. J Clin Oncol. 18:2000;2385-2394.
22. Sledge G.W. Jr, Hu P., Falkson G., Tormey D., Abeloff M. Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol. 18:2000;262-266.
23. Greenberg P.A., Hortobagyi G.N., Smith T.L., Ziegler L.D., Frye D.K., Buzdar A.U. Long-term follow-up of patients with CR following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 14:1996;2197-2205.
24. Rizzieri D.A., Vredenburgh J.J., Jones R., et al. Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support. J Clin Oncol. 17:1999;3064-3274.
25. Nieto Y., Nawaz S., Jones R.B., et al. Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer. J Clin Oncol. 20:2002;707-718.
26. Hortobagyi G.N. Can we cure limited metastatic breast cancer? J Clin Oncol. 20:2002;620-623.
27. Bruinvels D.J., Stiggelbout A.M., Kievit J., Van Houwelingen H.C., Habbema J.D., Van De Velde C.J. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 219:1994;174-182.
28. Einstein A.B. Jr. Hormonal therapy for prostate cancer. When to use it. Cancer Control. 2:1995;32-36.